BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Wu Y, Liu I, Ho C, Lee W, Chang C, Lan K, Ting G, Lee T, Shien J. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model. Nuclear Medicine and Biology 2012;39:35-43. [DOI: 10.1016/j.nucmedbio.2011.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen Z, Li J, Pan P, Bao P, Zeng X, Zhang X. Combination gut microbiota modulation and chemotherapy for orthotopic colorectal cancer therapy. Nano Today 2021;41:101329. [DOI: 10.1016/j.nantod.2021.101329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Chang CH, Chang MC, Chang YJ, Chen LC, Lee TW, Ting G. Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. Int J Mol Sci 2021;22:3868. [PMID: 33918011 DOI: 10.3390/ijms22083868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Huang YS, Hsu WC, Lin CH, Lo SN, Cheng CN, Lin MS, Lee TW, Chang CH, Lan KL. Bi-Functional Radiotheranostics of 188Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells. Int J Mol Sci 2021;22:1902. [PMID: 33672989 DOI: 10.3390/ijms22041902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
5 Zakarial Ansar FH, Latifah SY, Wan Kamal WHB, Khong KC, Ng Y, Foong JN, Gopalsamy B, Ng WK, How CW, Ong YS, Abdullah R, Aziz MY. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. Int J Nanomedicine 2020;15:7703-17. [PMID: 33116496 DOI: 10.2147/IJN.S262395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Das SS, Alkahtani S, Bharadwaj P, Ansari MT, ALKahtani MDF, Pang Z, Hasnain MS, Nayak AK, Aminabhavi TM. Molecular insights and novel approaches for targeting tumor metastasis. Int J Pharm 2020;585:119556. [PMID: 32574684 DOI: 10.1016/j.ijpharm.2020.119556] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 11.3] [Reference Citation Analysis]
7 Lo WL, Liang CH, Chen LC, Lee SY, Lo SN, Chen MW, Lu RM, Liu IJ, Wu HC, Chang CH. Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice. Appl Radiat Isot 2020;161:109162. [PMID: 32561130 DOI: 10.1016/j.apradiso.2020.109162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hafizi M, Kalanaky S, Moaiery H, Khayamzadeh M, Noorian S, Kaveh V, Gharib B, Foudazi H, Razavi M, Jenabian A, Salimi S, Sereshki MMA, Mirzaei HR, Zarghi A, Fakharzadeh S, Nazaran MH, Akbari ME. A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients. J Nanobiotechnology 2019;17:52. [PMID: 30971278 DOI: 10.1186/s12951-019-0484-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
9 Man F, Gawne PJ, T M de Rosales R. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 2019;143:134-60. [PMID: 31170428 DOI: 10.1016/j.addr.2019.05.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
10 Wei W, Rosenkrans ZT, Luo QY, Lan X, Cai W. Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy. Small Methods 2019;3:1800365. [PMID: 31355327 DOI: 10.1002/smtd.201800365] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kleynhans J, Grobler AF, Ebenhan T, Sathekge MM, Zeevaart J. Radiopharmaceutical enhancement by drug delivery systems: A review. Journal of Controlled Release 2018;287:177-93. [DOI: 10.1016/j.jconrel.2018.08.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
12 Chen LC, Lee WC, Ho CL, Chang YJ, Chen SJ, Chang CH. Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model. In Vivo 2018;32:567-73. [PMID: 29695562 DOI: 10.21873/invivo.11277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Chang CM, Lan KL, Huang WS, Lee YJ, Lee TW, Chang CH, Chuang CM. 188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept. Int J Mol Sci 2017;18:E903. [PMID: 28441355 DOI: 10.3390/ijms18050903] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
14 Chen LC, Chang YJ, Chen SJ, Lee WC, Chang CH, Lee TW, Shien JH. Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model. Int J Radiat Biol 2017;93:477-86. [PMID: 28045339 DOI: 10.1080/09553002.2017.1276308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shen YA, Lan KL, Chang CH, Lin LT, He CL, Chen PH, Lee TW, Lee YJ, Chuang CM. Intraperitoneal 188Re-Liposome delivery switches ovarian cancer metabolism from glycolysis to oxidative phosphorylation and effectively controls ovarian tumour growth in mice. Radiotherapy and Oncology 2016;119:282-90. [DOI: 10.1016/j.radonc.2016.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
16 Choi H, Lee Y, Hwang DW, Lee DS. Translational radionanomedicine: a clinical perspective. European Journal of Nanomedicine 2016;8. [DOI: 10.1515/ejnm-2015-0052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
17 Liang C, Xu L, Song G, Liu Z. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev 2016;45:6250-69. [DOI: 10.1039/c6cs00458j] [Cited by in Crossref: 291] [Cited by in F6Publishing: 302] [Article Influence: 41.6] [Reference Citation Analysis]
18 Chang CH, Liu SY, Chi CW, Yu HL, Chang TJ, Tsai TH, Lee TW, Chen YJ. External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics. Int J Nanomedicine 2015;10:3641-9. [PMID: 26056445 DOI: 10.2147/IJN.S80302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
19 Huang FY, Lee TW, Chang CH, Chen LC, Hsu WH, Chang CW, Lo JM. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model. Int J Nanomedicine 2015;10:463-73. [PMID: 25624760 DOI: 10.2147/IJN.S75955] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
20 Lin L, Chang C, Yu H, Liu R, Wang H, Chiu S, Chen F, Lee T, Lee Y. Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome–Embedded 188 Re on Human Non–Small Cell Lung Cancer Using an Orthotopic Small-Animal Model. J Nucl Med 2014;55:1864-70. [DOI: 10.2967/jnumed.114.140418] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
21 Hsu W, Liu S, Chang Y, Chang C, Ting G, Lee T. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model. Nuclear Medicine and Biology 2014;41:765-71. [DOI: 10.1016/j.nucmedbio.2014.05.142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
22 Dawidczyk CM, Russell LM, Searson PC. Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments. Front Chem 2014;2:69. [PMID: 25202689 DOI: 10.3389/fchem.2014.00069] [Cited by in Crossref: 88] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
23 Liu SY, Chang CH, Lee TW. Single dose acute toxicity testing for N,N-bis(2-mercaptoethyl)-N',N' diethylethylenediamine in beagles. Regul Toxicol Pharmacol 2014;69:217-25. [PMID: 24721389 DOI: 10.1016/j.yrtph.2014.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Chang CH, Liu SY, Lee TW. Pharmacokinetics of BMEDA after intravenous administration in beagle dogs. Molecules 2014;19:538-49. [PMID: 24394437 DOI: 10.3390/molecules19010538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Hsu CW, Chang YJ, Chang CH, Chen LC, Lan KL, Ting G, Lee TW. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts. Cancer Biother Radiopharm 2012;27:481-9. [PMID: 23067100 DOI: 10.1089/cbr.2011.1158] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
26 Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez-Gascón A. Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors. Eur J Pharm Biopharm 2013;84:309-14. [PMID: 23461861 DOI: 10.1016/j.ejpb.2013.01.029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
27 Chang Y, Hsu C, Chang C, Lan K, Ting G, Lee T. Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model. Invest New Drugs 2013;31:801-11. [DOI: 10.1007/s10637-012-9906-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
28 Petersen AL, Hansen AE, Gabizon A, Andresen TL. Liposome imaging agents in personalized medicine. Adv Drug Deliv Rev 2012;64:1417-35. [PMID: 22982406 DOI: 10.1016/j.addr.2012.09.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 126] [Article Influence: 10.7] [Reference Citation Analysis]